HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.

HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.
复制标题

DOI:
10.1038/leu.2015.8
复制
发表时间:
2015-06
期刊:
影响因子:
11.4
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

许多血液肿瘤患者不能动员足够数量的造血干细胞(HSC),以响应粒细胞集落刺激因子(G-CSF),排除随后的自体HSC移植。Plerixafor是趋化因子受体CXCR 4的特异性拮抗剂,可以挽救部分但不是所有单独使用G-CSF动员失败的患者。这些难治性动员不良者目前不能从自体移植中获益。为了发现增强HSC动员的替代靶向途径,我们研究了缺氧诱导因子-1 α(HIF-1α)的作用以及HIF-1α药理学稳定化对小鼠HSC动员的影响。我们在HSC特异性条件性缺失Hif 1a基因的小鼠中证明,氧不稳定转录因子HIF-1α对G-CSF和普乐沙福引起的HSC动员至关重要。相反,与目前临床上使用的最有效的动员组合G-CSF+普乐沙福相比,使用4-脯氨酰羟化酶抑制剂FG-4497对HIF-1α进行药理学稳定与G-CSF和普乐沙福协同作用,使重建HSC的动员增加20倍。
Many patients with hematological neoplasms fail to mobilize sufficient numbers of hematopoietic stem cells (HSCs) in response to granulocyte colony-stimulating factor (G-CSF) precluding subsequent autologous HSC transplantation. Plerixafor, a specific antagonist of the chemokine receptor CXCR4, can rescue some but not all patients who failed to mobilize with G-CSF alone. These refractory poor mobilizers cannot currently benefit from autologous transplantation. To discover alternative targetable pathways to enhance HSC mobilization, we studied the role of hypoxia-inducible factor-1α (HIF-1α) and the effect of HIF-1α pharmacological stabilization on HSC mobilization in mice. We demonstrate in mice with HSC-specific conditional deletion of the Hif1a gene that the oxygen-labile transcription factor HIF-1α is essential for HSC mobilization in response to G-CSF and Plerixafor. Conversely, pharmacological stabilization of HIF-1α with the 4-prolyl hydroxylase inhibitor FG-4497 synergizes with G-CSF and Plerixafor increasing mobilization of reconstituting HSCs 20-fold compared with G-CSF plus Plerixafor, currently the most potent mobilizing combination used in the clinic.
DOI: 10.1182/blood-2012-02-408419
发表时间: 2013-01-31
期刊: BLOOD
影响因子: 20.3
作者:
Forristal, Catherine E.;Winkler, Ingrid G.;Levesque, Jean-Pierre
通讯作者: Levesque, Jean-Pierre
DOI: 10.1038/nature11926
发表时间: 2013-03-14
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --
DOI: 10.1182/blood-2004-08-3037
发表时间: 2005-04-01
期刊: BLOOD
影响因子: 20.3
作者:
Göthert, JR;Gustin, SE;Begley, CG
通讯作者: Begley, CG
DOI: 10.1007/978-1-61779-943-3_11
发表时间: 2012-01-01
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者:
Barbier, Valerie;Winkler, Ingrid G;Levesque, Jean-Pierre
通讯作者: Levesque, Jean-Pierre
DOI: 10.1016/s0092-8674(00)81032-6
发表时间: 1996-02-23
期刊: CELL
影响因子: 64.5
作者:
Frenette, PS;Mayadas, TN;Wagner, DD
通讯作者: Wagner, DD